Acurx Pharmaceuticals, Inc. (ACXP)
Chart Events
Performance Outlook
| Previous Close | 2.7000 |
| Open | 2.7500 |
| Bid | 2.6000 x 1800 |
| Ask | 3.1500 x 800 |
| Day's Range | 2.6400 - 2.8800 |
| 52 Week Range | 2.5900 - 8.7400 |
| Volume | |
| Avg. Volume | 17,760 |
| Market Cap | 26.97M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4790 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
- PR Newswire
Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the quarter ended March 31, 2022.
- PR Newswire
Acurx Pharmaceuticals, Inc. to Discuss 2022 First Quarter Financial Results on May 11, 2022 Conference Call and Provide Business Update
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will release its 2022 first quarter financial results on Wednesday, May 11 2022, at 8:30 am ET before the U.S. financial markets open.
- Simply Wall St.
Acurx Pharmaceuticals (NASDAQ:ACXP) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. For example, although...
